Does sucralfate prevent apoptosis occurring in the ischemia/reperfusion-induced intestinal injury?

European Journal of Pediatric Surgery

Volumn 13, Issue 4, 2003, Pages 231-235

  Şencan, Aydin ^a,c   Yilmaz, O ^a   Ozer E ^b   Gunsar C ^a   Genc K ^a   Ulukus C ^b   Taneli, C ^a   Mir, E ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Apoptosis; Intestinal hypoxia; Necrotizing enterocolitis; Sucralfate

Indexed keywords

CELL DNA; DNA FRAGMENT; SUCRALFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; ILEUM; INFLAMMATION; INTESTINE CELL; INTESTINE INJURY; INTESTINE ISCHEMIA; MICROSCOPY; NECROTIZING ENTEROCOLITIS; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; PROPHYLAXIS; RAT; REPERFUSION INJURY;

ANIMALS; ANTI-ULCER AGENTS; APOPTOSIS; ENTEROCYTES; INTESTINAL DISEASES; INTESTINES; MODELS, ANIMAL; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY; SUCRALFATE;

EID: 0141625208     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42235     Document Type: Article

References (28)

1. Akman M, Akbal H, Emir H et al. The effects of sucralfate and selective intestinal decontamination on bacterial translocation. Pediatr Surg Int 2000; 16: 91-93
2. Albanese CT, Rowe MI. Necrotizing enterocolitis. In: O'Neill SA, Rowe MI, Grosfeld JL et al (eds.). Pediatric Surgery. 5th ed. St Louis, Missouri: Mosby Year Book, 2000: 1297-1320
3. Albanese CT, Rowe MI. Necrotizing enterocolitis. Semin Pediatr Surg 1995; 4: 200-206
4. Banda MA, Granger DN. Mechanism and protection from ischemic intestinal injury. Transplant Proc 1996; 28: 2595-2597
5. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10
6. Candelli M, Carloni E, Armuzzi A et al. Role of sucralfate in gastrointestinal diseases. Panminerva Med 2000; 42: 55-59
7. Caplan MS, Sun XM, Hseuh W et al. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990; 116: 960-964
8. Chen BW, Hiu WM, Lam SK et al. Effect of sucralfate on gastric mucosal blood flow in rats. Gut 1989; 30: 1544-1551
9. Dixon MF. The small intestine. In: R. Whitehead (ed.). Gastrointestinal and Oesophageal Pathology. 2nd ed. London: Churchill Livingstone, 1995: 665-686
10. Du X, Liu Q, Yang ZX et al. Protective effects of interleukin-11 in a murine model of ischemic cell death. Am J Pathol 1997; 146: 3-15
11. Ford HR, Sorrells DL, Knisely AS. Inflammatory cytokines, nitric oxide, and necrotizing enterocolitis. Semin Pediatr Surg 1996; 5: 155-159
12. Ford H, Watkins S, Reblock K et al. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997; 32: 275-282
13. Ikeda H, Suzuki Y, Suzuki M, et al. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut 1998; 42: 530-537
14. Kleinhaus S, Weinberg G, Gregor MB. Necrotizing enterocolitis in infancy. Surg Clin North Am 1992; 72: 261-276
15. Konturek SJ, Brzozowski T, Bielanski W et al. Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in rats. Am J Med 1989; 86: 32-37
16. Lorenzo MD, Krantis A. Altered nitric oxide production in the premature gut may increase susceptibility to intestinal damage in necrotizing enterocolitis. J Pediatr Surg 2001; 36: 700-705
17. McCarthy DM. Sucralfate. N Engl J Med 1991; 325: 1017-1025
18. Mcconkey DJ, Orrenius S. The role of calcium in the regulation of apoptosis. J Leukoc Biol 1996; 59: 775-783
19. Morecroft JA, Spitz L, Hamilton PA et al. Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatr Suppl 1994; 396: 18-20
20. Morecroft JA, Spitz L, Hamilton PA et al. Plasma interleukin-6 and tumour necrosis factor levels as predictors of disease severity and outcome in necrotizing enterocolitis. J Pediatr Surg 1994; 29: 798-800
21. Nadler EP, Dickinson E, Knisely A et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 2000; 92: 71-77
22. Parks DA, Granger DN. Ischemia induced vascular changes: Role of xanthine oxidase and hydroxyl radicals. Am J Physiol 1983; 245: G285-G289
23. Shah KA, Shurey S, Green CJ. Apoptosis after intestinal ischemia-reperfusion injury: A morphologic study. Transplantation 1997; 64: 1393-1397
24. Shah KA, Shurey S, Green CJ. Characterization of apoptosis in intestinal ischaemia-reperfusion injury: a light and electron microscopic study. Int J Exp Pathol 1997; 78: 355-363
25. Szabo S, Hollander D. Pathways of gastrointestinal protection and repair: mechanisms of action of sucralfate. Am J Med 1989; 86: 23-31
26. Şencan A, Karaca I, Şencan A et al. The effect of sucralfate on the management and prophylaxis of hypoxia/reoxygenation-induced intestinal injury in pup rats. XLIX Annual International Congress of the British Association of Paediatric Surgeons. 23-26 July 2002, Cambridge, UK.
27. Tarnawski A, Hollander D, Krause WJ et al. Does sucralfate affect the normal gastric mucosa? Gastroenterology 1986; 90: 893-905
28. Vergin H, Kori-Lindner C. Putative mechanisms of cytoprotective effect of certain antacids and sucralfate. Dig Dis Sci 1990; 35: 1320-1327